‘Good News for Women with Breast Cancer: many don’t need chemotherapy’ writes Denise Grady in the New York Times, 3 June 2018 reporting on a major international study.
The gene test, called Oncotype DX Breast Cancer Assay, is the focus of the study.
‘The availability of the gene test in 2004 helped researchers sort out women with very high or very low risk.
“But we really didn’t know what to do with women in the middle,” Dr. Mayer said. “Some seemed to benefit and some didn’t. We were back to square zero, safe rather than sorry, giving chemo to a lot who didn’t need it.”
“We can spare thousands and thousands of women from getting toxic treatment that really wouldn’t benefit them,” said Dr. Ingrid A. Mayer, from Vanderbilt University Medical Center, an author of the study. https://www.nytimes.com/2018/06/03/health/breast-cancer-chemo.html
– However, media cancer hype is usually followed by scientific/commonsense explanations and this ‘good news’ is no exception – see responses to the bmj article ‘Seven in 10 women with early breast cancer do not need chemotherapy, study finds’: